Market Research Future has a half-cooked Research report on the global Gastric Bypass
market.
Market Highlights:
Minimally invasive procedures are now being preferred by the healthcare provider and the
patients. Gastric bypass is one of the bariatric surgical procedures used to treat obesity
across the globe. Additionally, the progress of medical device industry in developed regions
across the globe also influences the demand for surgical devices. Diabetes and obesity are
the major risk factors for the cardiovascular disease, whose prevalence is found to be
increasing from last few years.
The Global Gastric Bypass Market is expected to grow at a CAGR of 6.1 % during the
forecast period 2017-2023.
Segmentation:
The Global Gastric Bypass Market is segmented on the basis of type, indication, and end
user. On the basis of type, it is segmented into endoscopic sleeve gastroplasty and
intragastric balloon. Based on the indication, it is segmented into obesity, gastroesophageal
reflux disease, heart disease, high blood pressure, type 2 diabetes, and others. On the basis
of the end user, it is segmented into hospitals & clinics, surgical centers, and others.
Get Premium Sample Copy @
https://www.marketresearchfuture.com/sample_request/5321
Key Players:
Some of key the players in the market are Medtronic (U.S.), Intuitive Surgical Inc. (U.S.),
TransEnterix Inc. (U.S.), ALLERGAN (Republic of Ireland), USGI Medical Inc. (U.S.), Cousin
Biotech (France), GI Dynamics Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.),
Mediflex Surgical Product (U.S.), and others.
Regional Analysis:
The Americas dominate the global gastric bypass market owing to the technological
advancement in the field of medical devices, a huge patient population with obesity and
diabetes and increasing healthcare spending. As per the Obesity Society, in the U.S., in
2014, 28.1% people were obese. The obesity prevalence ranged from 30.3% for men and
women aged 20-39 years to 39.5% and 35.4%, respectively, for men and women aged 40-
59 years and ages 60 and over.
Europe holds the second largest share of the global gastric bypass market as result of
increasing focus of various government agencies on the treatment of chronic diseases.
Additionally, the high prevalence of diabetes and increasing government support for
research & development influences the market growth. Moreover, rising awareness about
gastrointestinal diseases among the people also accelerates the market growth. According
to the World Health Organization (WHO), about 60 million European live with diabetes and
the prevalence of diabetes is relatively high among people over 25 years.
The Asia Pacific is expected to be a fastest growing market for gastric bypass owing to
increasing demand for minimally invasive procedures and huge geriatric population. Japan
holds the major share of the Asia Pacific market due to the availability of technologically
advanced medical devices and huge healthcare spending. Moreover, increasing healthcare
expenditure and the government’s initiatives for research & development projected to drive
the market in China and India over the forecasted period.
In the Middle East & Africa, the market exhibits steady owing to low technology penetration
in developing regions, and focus on primary care services. The United Arab Emirates (UAE),
Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas,
the African region is expected to witness a moderate growth.
Table of Content
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study